Gabapentin
Product Images NDC 50090-5961

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
The text describes a chart showing the mean pain score on a 4-week dose titration period followed by a 4-week fixed dose period. The chart compares the pain score under a placebo condition versus a high dose of gabapentin (3600 mg/day) condition. There is a baseline score (not specified) included in the chart.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

FDA Label Image

Label Image (Lbl500905961)

Label Image (Lbl500905961)
Product No. 9817-0 is a medication called "ThansenTIN" in 300 mg capsules. The recommended storage temperature is at 810 7 degrees Celsius. There are 33 loose capsules in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.